A molecular study on selected BRCA-1 and BRCA-2 germline mutations in breast, ovary and fallopian tube cancer cases in Turkey
Zeren, E.H.; Guveloglu, E.; Ergin, M.; Aras, D.; Gumurdulu, D.; Bayram, F.; Vardar, M.A.; Demircan, O.
Virchows Archiv 451(2): 505
2007
ISSN/ISBN: 0945-6317
Accession: 020639854
PDF emailed within 1 workday: $29.90
Related References
Schoolmeester, J.K.; Moyer, A.M.; Goodenberger, M.L.; Keeney, G.L.; Carter, J.M.; Bakkum-Gamez, J.N. 2017: Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2 Human Pathology 70: 14-26Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329
Chen, B.; Zhang, G.; Li, X.; Ren, C.; Wang, Y.; Li, K.; Mok, H.; Cao, L.; Wen, L.; Jia, M.; Li, C.; Guo, L.; Wei, G.; Lin, J.; Li, Y.; Zhang, Y.; Han-Zhang, H.; Liu, J.; Lizaso, A.; Liao, N. 2020: Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer Aging 12(4): 3140-3155
Choi, M.C.; Bae, J.S.; Jung, S.G.; Park, H.; Joo, W.D.; Song, S.H.; Lee, C.; Kim, J.H.; Lee, K.C.; Lee, S.; Lee, J.H. 2018: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube Journal of Gynecologic Oncology 29(4): E43
Agoff, S.N.; Garcia, R.L.; Goff, B.; Swisher, E. 2004: Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations American Journal of Surgical Pathology 28(8): 1112-1114
Choi, M.Chul.; Bae, J.Sik.; Jung, S.Geun.; Park, H.; Joo, W.Duk.; Song, S.Hun.; Lee, C.; Kim, J.Ho.; Lee, K.Chan.; Lee, S.; Lee, J.Ho. 2018: Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube Journal of gynecologic oncology 29(5): e80
Huang, X.; Shao, D.; Wu, H.; Zhu, C.; Guo, D.; Zhou, Y.; Chen, C.; Lin, Y.; Lu, T.; Zhao, B.; Wang, C.; Sun, Q. 2020: Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients with Triple-Negative Breast Cancer Frontiers in Oncology 10: 583314
Ansink, A.C.; Burger, C.W.; Seynaeve, C. 2001: Occult cancer in the fallopian tube in patients with a BRCA-1 germline mutation Gynecologic Oncology 83(2): 445
Carcangiu, M.L.; Radice, P.; Spatti, G.; Pasini, B. 2002: Dysplastic changes of the fallopian tubes in BRCA-1 and BRCA-2 germline mutation carriers at prophylactic oophorectomy Laboratory Investigation 82(1): 193A
Lee, C.Khoon.; Scott, C.; Lindeman, G.J.; Hamilton, A.; Lieschke, E.; Gibbs, E.; Asher, R.; Badger, H.; Paterson, R.; Macnab, L.; Kwan, E.Michael.; Francis, P.A.; Boyle, F.; Friedlander, M. 2019: Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer British Journal of Cancer 120(3): 279-285
Skrzypczyk-Ostaszewicz, A. 2022: Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer Drugs of Today 58(6): 299-309
Aydin, F.; Akagun, T.; Yildiz, B.; Fidan, E.; Ozdemir, F.; Kavgaci, H. 2011: Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer Bratislavske Lekarske Listy 112(9): 521-523
Paley, P.J.; Swisher, E.M.; Garcia, R.L.; Agoff, S.N.; Greer, B.E.; Peters, K.L.; Goff, B.A. 2001: Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecologic Oncology 80(2): 176-180
Sakurada, S.; Watanabe, Y.; Tokunaga, H.; Takahashi, F.; Yamada, H.; Takehara, K.; Yaegashi, N. 2018: Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women Japanese Journal of Clinical Oncology 48(9): 794-798
Begg, C.B.; Satagopan, J.M.; Robson, M.; Offit, K. 1999: Lifetime breast cancer risk associated with BRCA 1 and BRCA 2 mutations among patients of Ashkenazi Jewish origin American Journal of Human Genetics 65(4): A61
Mehra, K.K.; Chang, M.C.; Folkins, A.K.; Raho, C.J.; Lima, J.F.; Yuan, L.; Mehrad, M.; Tworoger, S.S.; Crum, C.P.; Saleemuddin, A. 2011: The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 24(1): 152-156
Tung, N. 2011: Management of women with BRCA mutations: a 41-year-old woman with a BRCA mutation and a recent history of breast cancer JAMA 305(21): 2211-2220
Verma, S.; Dent, S.F.; Paquet, L.; Bitonti, L. 2016: When the BRCA test is negative-Prevention strategies in women who have no detectable mutation (BRCA-) compared to women harboring positive BRCA mutations (BRCA+) Journal of Clinical Oncology 26(15_Suppl): 1534-1534
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: P2: Snp Analysis in Brca Positive and Brca Negative Subjects with and without Breast Cancer (Brca) Reveal Central Role of Alk Snps and Tgfbeta Superfamily in Malignant Transformation Journal of Investigative Medicine 64(3): 817.3-818
Lambertini, M.; Ameye, L.; Hamy, A.-S.; Zingarello, A.; Poorvu, P.D.; Carrasco, E.; Grinshpun, A.; Han, S.; Rousset-Jablonski, C.; Ferrari, A.; Paluch-Shimon, S.; Cortesi, L.; Senechal, C.; Miolo, G.; Pogoda, K.; Pérez-Fidalgo, J.A.; De Marchis, L.; Ponzone, R.; Livraghi, L.; Estevez-Diz, M.D.P.; Villarreal-Garza, C.; Dieci, M.V.; Clatot, F.; Berlière, M.; Graffeo, R.; Teixeira, L.; Córdoba, O.; Sonnenblick, A.; Luna Pais, H.; Ignatiadis, M.; Paesmans, M.; Partridge, A.H.; Caron, O.; Saule, C.; Del Mastro, L.; Peccatori, F.A.; Azim, H.A. 2020: Pregnancy After Breast Cancer in Patients with Germline BRCA Mutations Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 38(26): 3012-3023